Exploring cancer genomics at the University of Melbourne Center for Cancer Research
Joined August 2007
- Tweets3.9K
- Following882
- Followers1.9K
- Likes4K
Oliver Hofmann retweeted
Here’s a nice analysis of 2.5M children about Tylenol and autism. The study found a small association between tylenol use in pregnancy and autism, but the association went away in sibling analysis. In sibling analysis you compare children born to the same mother where one child was exposed to Tylenol but not the other. This is a better comparison because genetics are similar between siblings whereas they differ greatly in non siblings from different families. Bottom line: no increased risk of autism with tylenol use in a huge population analysis. jamanetwork.com/journals/jam…
Oliver Hofmann retweeted
In case anyone thinks ANY president can declare victory on a major medical advancement from secret information that the broader scientific community is unaware of, that’s literally not a thing. This isn’t how science works and among the reasons that a handful of secret people, no matter what their claimed expertise, should never claim to adjudicate scientific truth — whether via journals or whatever the hell this is
Oliver Hofmann retweeted
The @GenCancerCentre at @UniMelb is seeking a Senior Research Fellow/Group Leader to drive advances in genomic cancer medicine - click the link to see more. ozmrs.com/job-opportunities
Oliver Hofmann retweeted
Only 2 weeks left to get legislation through before the next election in Australia to protect anyone who engages with genetic and genomic research from having to worry about it impacting their insurance.
Please urge your local MP to make this happen
abc.net.au/news/2025-01-29/g…
Oliver Hofmann retweeted
Lots of people that like to call others 'triggered snowflakes' are very, very upset about a naughty word on a t-shirt
Oliver Hofmann retweeted
Your Phase 3, derisked biotech is trading at a fraction of peak sales while the Jurassic Park company hits $10B
Sharing our Series C funding round, which makes Colossal the first Texas-based company valued over $10 billion 💪🦣🧬
Via @VentureBeat:
“Our recent successes in creating the technologies necessary for our end-to-end de-extinction toolkit have been met with enthusiasm by the investor community. TWG Global and our other partners have been bullish in their desire to help us scale as quickly and efficiently as possible,” said CEO Colossal Ben Lamm, in a statement. “This funding will grow our team, support new technology development, expand our de-extinction species list, while continuing to allow us to carry forth our mission to make extinction a thing of the past.”
Oliver Hofmann retweeted
The NIST National Cybersecurity Center of Excellence (NCCoE) has released two new draft publications to help organizations address cybersecurity and privacy risks associated with processing genomic data. Both drafts are open for public comment through Jan 2025 1/
Oliver Hofmann retweeted
👉 Out now @NatureRevGenet: we CAN and we SHOULD do more to enable #genomic data sharing! 🧬🌏
👉Best practice examples and 12 actions we can all take together
👉 rdcu.be/dWfsu
@GA4GH @AusGenomics @GenomicsEngland @NHSgms @AllofUsResearch @uk_biobank @ukfuturehealth
Oliver Hofmann retweeted
GA4GH 12th Plenary 🤩
🇦🇺: Melbourne, Australia and online
👥: 650 registrants
🌐: 44 countries
💼: 3 meetings, 65 sessions
Big thanks to our co-host, @AusGenomics 🤝
🇸🇪: 13th Plenary will be in Uppsala, Sweden
Read the full Plenary recap here: hubs.li/Q02QxcQt0
Oliver Hofmann retweeted
The weird thing about "fixing" technical debt is you often need substantial money to basically gut and redo the backend/software, and sensible goal is to have exactly the same interfaces to the users. This feels ... weird to funders.
Oliver Hofmann retweeted
Welcome to GA4GH 12th Plenary! This week, we are gathering to advance responsible sharing of genomic and related health data, for the benefit of human health. Learn how you can participate this week, from wherever you are located: bit.ly/4e5Hlg1
Oliver Hofmann retweeted
Thrilled to see this pilot program investing directly in maintainers — both financially and through mentorship. If you maintain critical parts of our open digital infrastructure, apply!!
Last month, we introduced the fellowship for maintainers. Today we’re happy to unveil details & start accepting applications. We’re looking for up to five maintainers for the inaugural fellowship!
Apply by 20 Oct 2024 to join the pilot cohort 🎉 1/2 sovereigntechfund.de/news/ap…
Oliver Hofmann retweeted
Air purifiers in Finnish daycare reduced children's illnesses by 18% in a carefully controlled study. This implies huge potential for better public health and cost savings from sick leaves, with a simple intervention against airborne infections.
yle.fi/a/74-20089670
Oliver Hofmann retweeted
Excited to be presenting at the @GA4GH 12th Plenary in Melbourne. So, many interesting talks and participants!
✨ #GA4GHPlenary #Genomics #GlobalOmics
Oliver Hofmann retweeted
Very excited to be in Australia the next 2 weeks. On Wednesday 11th September I am speaking @MCRI_for_kids - Murdoch Children's Institute research on our latest work modelling human health trajectories and the extent of Gene x Environment in humans and other vertebrates
Oliver Hofmann retweeted
Professor @RadvanyiLaszlo, director of the Ontario Institute for Cancer Research, will be introducing the work of @OICR_news in a special UMCCR seminar on Tuesday, 17 September.
👉Click through to register to attend in-person or via Zoom: go.unimelb.edu.au/h9w8
Oliver Hofmann retweeted
Every grad program needs to ensure their students are aware that even of you squeeze thru the bottleneck & get a faculty position, the numbers in the 2019 plot shown here have gotten worse: now you need 25 proposals to get 95% probability of funding, as drug monkey updates here
Grant submission vigor drugmonkey.scientopia.org/20… via @drugmonkeyblog
We are happy to announce the release of a new #nf-core workflow -- #oncoanalyser performs an exhaustive analysis of single-patient cancer sequencing data using methods developed by the Hartwig Medical Foundation Australia. (1/6) :thread:
We are excited to make this pipeline more widely available to the cancer research and clinical community through #nf-core and would love to hear your feedback. (5/6)